These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8549651

  • 1. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
    Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C.
    Exp Cell Res; 1996 Jan 10; 222(1):103-10. PubMed ID: 8549651
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
    Evangelou A, Jindal SK, Brown TJ, Letarte M.
    Cancer Res; 2000 Feb 15; 60(4):929-35. PubMed ID: 10706107
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB, Moody TW, Mariano JM.
    Anticancer Res; 1997 Feb 15; 17(3C):1849-60. PubMed ID: 9216635
    [Abstract] [Full Text] [Related]

  • 10. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells.
    Bruckheimer EM, Kyprianou N.
    Prostate; 2002 Oct 01; 53(2):133-42. PubMed ID: 12242728
    [Abstract] [Full Text] [Related]

  • 11. Stromal cells of the human prostate: initial isolation and characterization.
    Kassen A, Sutkowski DM, Ahn H, Sensibar JA, Kozlowski JM, Lee C.
    Prostate; 1996 Feb 01; 28(2):89-97. PubMed ID: 8604397
    [Abstract] [Full Text] [Related]

  • 12. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
    Lucia MS, Sporn MB, Roberts AB, Stewart LV, Danielpour D.
    J Cell Physiol; 1998 May 01; 175(2):184-92. PubMed ID: 9525477
    [Abstract] [Full Text] [Related]

  • 13. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 14. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG.
    Eur Urol; 2005 Dec 01; 48(6):1051-8. PubMed ID: 16257107
    [Abstract] [Full Text] [Related]

  • 15. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K, Kumagai T, Shimizu T, Takeda K.
    Int J Mol Med; 2005 Feb 01; 15(2):253-8. PubMed ID: 15647840
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT, Le H, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2005 Mar 15; 288(3):E573-84. PubMed ID: 15536203
    [Abstract] [Full Text] [Related]

  • 19. Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells.
    Evangelou A, Letarte M, Jurisica I, Sultan M, Murphy KJ, Rosen B, Brown TJ.
    Cancer Res; 2003 May 15; 63(10):2416-24. PubMed ID: 12750261
    [Abstract] [Full Text] [Related]

  • 20. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K, Cornelius SC, Danielpour D.
    Cancer Res; 2003 Aug 01; 63(15):4358-67. PubMed ID: 12907605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.